© The Board of Management and Trustees of the British Journal of Anaesthesia 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
The doughnut and the hole: a new pharmacological concept for anaesthetists
| The first 150 words of the full text of this article appear below. |
It is time for anaesthetists to revisit a long acknowledged but little considered concept in clinical pharmacology. In our daily practice, we regularly think about the law of mass action, about reversible reactions and about diffusion gradients. We accept that passive diffusion along concentration gradients is a common cause of the pharmacological effects we utilize in every anaesthetic. Thus it is easy to conceive of recovery from neuromuscular block induced by the depolarizing agent, succinylcholine, occurring as the concentration of the drug reduces in the plasma following metabolism by plasma cholinesterase. The drug moves passively from the higher concentration at the postsynaptic nicotinic receptor back in to the plasma and recovery occurs. We also accept that if a further bolus dose of such a drug is given, neuromuscular block recurs: the balance of concentration of the drug would be shifted in the opposite direction.
From our undergraduate pharmacology days, we
Cyclic oligosaccharides
Do we need a new neuromuscular antagonist?
Chelation (or encapsulation)
Dynamics of sugammadex (Org 25969)
Side-effects
The future
University Department of Anaesthesia, Clinical Science Duncan Building, Daulby Street, Liverpool L69 3GA, UK
*E-mail: bja@liv.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Srivastava and J. M. Hunter Reversal of neuromuscular block Br. J. Anaesth., July 1, 2009; 103(1): 115 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Staals, M. M. J. Snoeck, J. J. Driessen, E. A. Flockton, M. Heeringa, and J. M. Hunter Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function Br. J. Anaesth., October 1, 2008; 101(4): 492 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Eikermann, S. Zaremba, A. Malhotra, A. S. Jordan, C. Rosow, and N. L. Chamberlin Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing Br. J. Anaesth., September 1, 2008; 101(3): 344 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Lambert Volume 100: basic sciences in the British Journal of Anaesthesia Br. J. Anaesth., May 1, 2008; 100(5): 595 - 596. [Full Text] [PDF]
|
|
|
|
|
|
C. Claudius, H. Karacan, and J. Viby-Mogensen Prolonged residual paralysis after a single intubating dose of rocuronium Br. J. Anaesth., October 1, 2007; 99(4): 514 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Sacan, P. F. White, B. Tufanogullari, and K. Klein Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Neostigmine-Glycopyrrolate and Edrophonium-Atropine Anesth. Analg., March 1, 2007; 104(3): 569 - 574. [Abstract] [Full Text] [PDF]
|
|
E-letters:
Read all E-letters
- Error in the text
- Ian M. Bishton
- British Journal of Anaesthesia, 11 Jul 2006 [Full text]